NVS is a long term reliable dividend paying hold, but I try to be careful with pharmas. A lot of possible catalysts that can change the direction too soon.
This is purely a trend line analysis. I see good indicators from trend lines in play and looks like the stock will re test the $98 high again before either a move up or down. I expect it to break downward by 2022.
Caution: slow moving stock. It won't bleed your portfolio on red days, but watching paint dry would be a lot quicker than watching NVS go up a few percentage.
Good luck!
This is purely a trend line analysis. I see good indicators from trend lines in play and looks like the stock will re test the $98 high again before either a move up or down. I expect it to break downward by 2022.
Caution: slow moving stock. It won't bleed your portfolio on red days, but watching paint dry would be a lot quicker than watching NVS go up a few percentage.
Good luck!
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。